PNPLA8 Antikörper (Middle Region)
-
- Target Alle PNPLA8 Antikörper anzeigen
- PNPLA8 (Patatin-Like phospholipase Domain Containing 8 (PNPLA8))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Maus, Ratte, Kaninchen, Pferd, Rind (Kuh), Hund, Meerschweinchen, Zebrafisch (Danio rerio)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PNPLA8 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- IDNRTRALVQ ALRRTTDPKL CITRVEELTF HLLEFPEGKG VAVKERIIPY
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 92%
- Produktmerkmale
- This is a rabbit polyclonal antibody against PNPLA8. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human PNPLA8
- Top Product
- Discover our top product PNPLA8 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 782 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes." in: PLoS ONE, Vol. 8, Issue 8, pp. e71748, (2013) (PubMed).
: "
-
Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes." in: PLoS ONE, Vol. 8, Issue 8, pp. e71748, (2013) (PubMed).
-
- Target
- PNPLA8 (Patatin-Like phospholipase Domain Containing 8 (PNPLA8))
- Andere Bezeichnung
- PNPLA8 (PNPLA8 Produkte)
- Synonyme
- IPLA2(GAMMA) antikoerper, IPLA2-2 antikoerper, IPLA2G antikoerper, iPLA2gamma antikoerper, 1200006O19Rik antikoerper, AI467579 antikoerper, Ipla2(gamma) antikoerper, RGD1311444 antikoerper, iPLA2 antikoerper, patatin like phospholipase domain containing 8 antikoerper, patatin-like phospholipase domain containing 8 antikoerper, PNPLA8 antikoerper, Pnpla8 antikoerper
- Hintergrund
-
Phospholipase A2 catalyzes cleavage of fatty acids from phospholipids, thereby regulating membrane physical properties and the release of lipid second messengers and growth factors. Phospholipase A2 activity also modulates cellular growth programs, inflam
Alias Symbols: IPLA2(GAMMA), IPLA2-2, IPLA2G
Protein Interaction Partner: UBC,
Protein Size: 782 - Molekulargewicht
- 88 kDa
- Gen-ID
- 50640
- NCBI Accession
- NM_015599, NP_056538
- UniProt
- Q9NP80
-